Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Hepatitis C”

1,207 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,207 results

Testing effectiveness (Phase 2)Study completedNCT00537407
What this trial is testing

Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 50
Not applicableStudy completedNCT00005657
What this trial is testing

Genetics of Hepatitis C Virus Infection

Who this might be right for
Hepatitis CLiver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 870
Testing effectiveness (Phase 2)UnknownNCT00703872
What this trial is testing

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hepasome Pharmaceuticals 50
Post-approval studies (Phase 4)UnknownNCT00887081
What this trial is testing

Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies

Who this might be right for
Hemoglobinopathies
Azienda Ospedaliera V. Cervello 150
Large-scale testing (Phase 3)Study completedNCT00687219
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 102
Testing effectiveness (Phase 2)Ended earlyNCT02605304
What this trial is testing

12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF

Who this might be right for
HIV-1 InfectionHepatitis C
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 7
Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Large-scale testing (Phase 3)Study completedNCT01909557
What this trial is testing

Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.

Who this might be right for
Quality of LifeDaily ActivityFatigue
University of Catania 62
Large-scale testing (Phase 3)Study completedNCT00301509
What this trial is testing

Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

Who this might be right for
Liver Cirrhosis, Experimental
Casa Sollievo della Sofferenza IRCCS
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Not applicableStudy completedNCT02103699
What this trial is testing

Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir

Who this might be right for
Hepatitis C Virus
Janssen Scientific Affairs, LLC 315
Not applicableUnknownNCT04510246
What this trial is testing

Link Hepatitis C Notifications to Treatment in Tasmania

Who this might be right for
Hepatitis C
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 170
Testing effectiveness (Phase 2)Study completedNCT01221298
What this trial is testing

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 11
Large-scale testing (Phase 3)Study completedNCT02473211
What this trial is testing

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 106
Not applicableStudy completedNCT00727311
What this trial is testing

Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 2,302
Early research (Phase 1)Study completedNCT00749138
What this trial is testing

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

Who this might be right for
Chronic Hepatitis C
Bader, Ted, M.D. 18
Large-scale testing (Phase 3)Study completedNCT01896193
What this trial is testing

Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 127
Large-scale testing (Phase 3)Study completedNCT01497366
What this trial is testing

Phase 3 Study of Sofosbuvir and Ribavirin

Who this might be right for
Hepatitis C
Gilead Sciences 527
Testing effectiveness (Phase 2)Ended earlyNCT00582738
What this trial is testing

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Who this might be right for
Recurrent Hepatitis C
Novartis Pharmaceuticals 43
Load More Results